Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 3.81
CCEL's Cash to Debt is ranked higher than
74% of the 239 Companies
in the Global Medical Care industry.

( Industry Median: 0.36 vs. CCEL: 3.81 )
Ranked among companies with meaningful Cash to Debt only.
CCEL' s Cash to Debt Range Over the Past 10 Years
Min: 0.17  Med: 10000.00 Max: No Debt
Current: 3.81
Equity to Asset -0.28
CCEL's Equity to Asset is ranked lower than
97% of the 232 Companies
in the Global Medical Care industry.

( Industry Median: 0.45 vs. CCEL: -0.28 )
Ranked among companies with meaningful Equity to Asset only.
CCEL' s Equity to Asset Range Over the Past 10 Years
Min: -1.05  Med: -0.10 Max: 0.92
Current: -0.28
-1.05
0.92
Interest Coverage 1.95
CCEL's Interest Coverage is ranked lower than
80% of the 190 Companies
in the Global Medical Care industry.

( Industry Median: 6.25 vs. CCEL: 1.95 )
Ranked among companies with meaningful Interest Coverage only.
CCEL' s Interest Coverage Range Over the Past 10 Years
Min: 1.18  Med: 1.72 Max: 2.51
Current: 1.95
1.18
2.51
F-Score: 6
Z-Score: 0.26
M-Score: 0.40
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 11.51
CCEL's Operating margin (%) is ranked higher than
64% of the 235 Companies
in the Global Medical Care industry.

( Industry Median: 7.46 vs. CCEL: 11.51 )
Ranked among companies with meaningful Operating margin (%) only.
CCEL' s Operating margin (%) Range Over the Past 10 Years
Min: -26.76  Med: 3.71 Max: 18.27
Current: 11.51
-26.76
18.27
Net-margin (%) 35.97
CCEL's Net-margin (%) is ranked higher than
97% of the 238 Companies
in the Global Medical Care industry.

( Industry Median: 4.79 vs. CCEL: 35.97 )
Ranked among companies with meaningful Net-margin (%) only.
CCEL' s Net-margin (%) Range Over the Past 10 Years
Min: -35.1  Med: -2.13 Max: 38.43
Current: 35.97
-35.1
38.43
ROA (%) 48.42
CCEL's ROA (%) is ranked higher than
99% of the 236 Companies
in the Global Medical Care industry.

( Industry Median: 3.78 vs. CCEL: 48.42 )
Ranked among companies with meaningful ROA (%) only.
CCEL' s ROA (%) Range Over the Past 10 Years
Min: -39.68  Med: -3.20 Max: 54.57
Current: 48.42
-39.68
54.57
ROC (Joel Greenblatt) (%) 201.98
CCEL's ROC (Joel Greenblatt) (%) is ranked higher than
94% of the 234 Companies
in the Global Medical Care industry.

( Industry Median: 17.56 vs. CCEL: 201.98 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
CCEL' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: -240.91  Med: 69.84 Max: 245.96
Current: 201.98
-240.91
245.96
Revenue Growth (3Y)(%) 10.70
CCEL's Revenue Growth (3Y)(%) is ranked higher than
64% of the 173 Companies
in the Global Medical Care industry.

( Industry Median: 7.60 vs. CCEL: 10.70 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
CCEL' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: -18  Med: 10.70 Max: 97.8
Current: 10.7
-18
97.8
» CCEL's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Insider Trades

Latest Guru Trades with CCEL

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 4.11
CCEL's P/E(ttm) is ranked higher than
94% of the 176 Companies
in the Global Medical Care industry.

( Industry Median: 25.73 vs. CCEL: 4.11 )
Ranked among companies with meaningful P/E(ttm) only.
CCEL' s P/E(ttm) Range Over the Past 10 Years
Min: 3.49  Med: 17.08 Max: 520
Current: 4.11
3.49
520
PE(NRI) 4.11
CCEL's PE(NRI) is ranked higher than
95% of the 176 Companies
in the Global Medical Care industry.

( Industry Median: 25.73 vs. CCEL: 4.11 )
Ranked among companies with meaningful PE(NRI) only.
CCEL' s PE(NRI) Range Over the Past 10 Years
Min: 3.48  Med: 15.83 Max: 114
Current: 4.11
3.48
114
Price/Owner Earnings (ttm) 2.82
CCEL's Price/Owner Earnings (ttm) is ranked higher than
97% of the 90 Companies
in the Global Medical Care industry.

( Industry Median: 26.24 vs. CCEL: 2.82 )
Ranked among companies with meaningful Price/Owner Earnings (ttm) only.
CCEL' s Price/Owner Earnings (ttm) Range Over the Past 10 Years
Min: 2.39  Med: 11.89 Max: 377.14
Current: 2.82
2.39
377.14
P/S 1.46
CCEL's P/S is ranked higher than
55% of the 232 Companies
in the Global Medical Care industry.

( Industry Median: 1.56 vs. CCEL: 1.46 )
Ranked among companies with meaningful P/S only.
CCEL' s P/S Range Over the Past 10 Years
Min: 0.28  Med: 1.35 Max: 3.52
Current: 1.46
0.28
3.52
PFCF 7.11
CCEL's PFCF is ranked higher than
91% of the 114 Companies
in the Global Medical Care industry.

( Industry Median: 21.39 vs. CCEL: 7.11 )
Ranked among companies with meaningful PFCF only.
CCEL' s PFCF Range Over the Past 10 Years
Min: 4.05  Med: 15.24 Max: 218.46
Current: 7.11
4.05
218.46
POCF 6.91
CCEL's POCF is ranked higher than
83% of the 153 Companies
in the Global Medical Care industry.

( Industry Median: 14.93 vs. CCEL: 6.91 )
Ranked among companies with meaningful POCF only.
CCEL' s POCF Range Over the Past 10 Years
Min: 3.33  Med: 12.43 Max: 277
Current: 6.91
3.33
277
EV-to-EBIT 14.86
CCEL's EV-to-EBIT is ranked higher than
64% of the 179 Companies
in the Global Medical Care industry.

( Industry Median: 19.52 vs. CCEL: 14.86 )
Ranked among companies with meaningful EV-to-EBIT only.
CCEL' s EV-to-EBIT Range Over the Past 10 Years
Min: -78.2  Med: 3.80 Max: 142.6
Current: 14.86
-78.2
142.6
EV-to-EBITDA 12.98
CCEL's EV-to-EBITDA is ranked higher than
52% of the 193 Companies
in the Global Medical Care industry.

( Industry Median: 13.44 vs. CCEL: 12.98 )
Ranked among companies with meaningful EV-to-EBITDA only.
CCEL' s EV-to-EBITDA Range Over the Past 10 Years
Min: -74.6  Med: 3.90 Max: 177
Current: 12.98
-74.6
177
Current Ratio 0.98
CCEL's Current Ratio is ranked lower than
69% of the 225 Companies
in the Global Medical Care industry.

( Industry Median: 1.36 vs. CCEL: 0.98 )
Ranked among companies with meaningful Current Ratio only.
CCEL' s Current Ratio Range Over the Past 10 Years
Min: 0.47  Med: 1.40 Max: 35.3
Current: 0.98
0.47
35.3
Quick Ratio 0.93
CCEL's Quick Ratio is ranked lower than
66% of the 225 Companies
in the Global Medical Care industry.

( Industry Median: 1.27 vs. CCEL: 0.93 )
Ranked among companies with meaningful Quick Ratio only.
CCEL' s Quick Ratio Range Over the Past 10 Years
Min: 0.47  Med: 1.40 Max: 35.3
Current: 0.93
0.47
35.3
Days Inventory 19.38
CCEL's Days Inventory is ranked lower than
52% of the 166 Companies
in the Global Medical Care industry.

( Industry Median: 17.59 vs. CCEL: 19.38 )
Ranked among companies with meaningful Days Inventory only.
CCEL' s Days Inventory Range Over the Past 10 Years
Min: 2.07  Med: 9.79 Max: 17.5
Current: 19.38
2.07
17.5
Days Sales Outstanding 54.87
CCEL's Days Sales Outstanding is ranked lower than
68% of the 204 Companies
in the Global Medical Care industry.

( Industry Median: 44.25 vs. CCEL: 54.87 )
Ranked among companies with meaningful Days Sales Outstanding only.
CCEL' s Days Sales Outstanding Range Over the Past 10 Years
Min: 25.79  Med: 51.88 Max: 73.85
Current: 54.87
25.79
73.85
Days Payable 107.89
CCEL's Days Payable is ranked higher than
73% of the 155 Companies
in the Global Medical Care industry.

( Industry Median: 42.56 vs. CCEL: 107.89 )
Ranked among companies with meaningful Days Payable only.
CCEL' s Days Payable Range Over the Past 10 Years
Min: 49.91  Med: 82.68 Max: 104.76
Current: 107.89
49.91
104.76

Valuation & Return

vs
industry
vs
history
Price/Projected FCF 3.25
CCEL's Price/Projected FCF is ranked lower than
84% of the 85 Companies
in the Global Medical Care industry.

( Industry Median: 1.71 vs. CCEL: 3.25 )
Ranked among companies with meaningful Price/Projected FCF only.
CCEL' s Price/Projected FCF Range Over the Past 10 Years
Min: 3  Med: 5.64 Max: 58
Current: 3.25
3
58
Price/Median PS Value 1.08
CCEL's Price/Median PS Value is ranked lower than
53% of the 187 Companies
in the Global Medical Care industry.

( Industry Median: 1.04 vs. CCEL: 1.08 )
Ranked among companies with meaningful Price/Median PS Value only.
CCEL' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.29  Med: 1.27 Max: 67.6
Current: 1.08
0.29
67.6
Earnings Yield (Greenblatt) (%) 6.70
CCEL's Earnings Yield (Greenblatt) (%) is ranked higher than
71% of the 223 Companies
in the Global Medical Care industry.

( Industry Median: 4.10 vs. CCEL: 6.70 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
CCEL' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 0.7  Med: 9.20 Max: 642.2
Current: 6.7
0.7
642.2

More Statistics

Revenue(Mil) $21
EPS $ 0.79
Beta-0.48
Short Percentage of Float0.00%
52-Week Range $2.12 - 3.95
Shares Outstanding(Mil)9.09

Business Description

Industry: Health Care Providers » Medical Care
Compare:SGX:5OT, TSX:CHH, XKLS:137, IST:LKMNH.Y, JSE:AVL » details
Cryo-Cell International, Inc. was incorporated on September 11, 1989 in the State of Delaware. The Company is engaged in cellular processing and cryogenic storage, with a current focus on the collection and preservation of umbilical cord (U-Cord9(r)) blood stem cells for family use. The Company has established private family cord blood stem cell banks in terms of the number of specimens preserved. Its headquarters facility in Oldsmar, Florida handles all aspects of its U.S.-based business operations, including the processing and storage of specimens. The specimens are stored in commercially available cryogenic storage units at the Company's technologically and operationally advanced facility in Oldsmar, Florida. It has expanded its research and development activities to develop technologies related to stem cells other than umbilical cord blood stem cells. During 2006, in parallel with its R&D associated with placental stem cells, the Company discovered novel technology related to menstrual stem cells. In November 2007, the Company announced the launch of its C'elleSM service related to this patent-pending technology, and the Company continues to focus its current research and development activities mainly on the C'elle service and related new menstrual stem cell technologies. The Company is actively marketing the C'elle service both through a bundled offer with the Company's U-Cord service and on a stand-alone basis. The Company markets its cord blood stem cell preservation services directly to expectant parents and by distributing information through obstetricians, pediatricians, Lamaze instructors and other childbirth educators, certified nurse-midwives and other related healthcare professionals. To increase awareness among expectant parent audiences, the Company continues to promote its service in several national targeted prenatal magazines including American Baby and Fit Pregnancy, as well as several magazines distributed during childbirth classes. Expectant parents have also received information via emails and the Company has increased its internet marketing campaigns. Its competitors are Cord Blood Registry, Inc., ViaCord, a division of ViaCell, Inc., a wholly-owned subsidiary of PerkinElmer and LifeBankUSA, a division of Celgene. The Company is required to register with the FDA under the Public Health Service Act.
» More Articles for CCEL

Headlines

Articles On GuruFocus.com
No related article found.

More From Other Websites
Cryo-Cell International, Inc. :CCEL-US: Earnings Analysis: Q1, 2016 By the Numbers Apr 21 2016
CRYO CELL INTERNATIONAL INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial... Apr 20 2016
CRYO CELL INTERNATIONAL INC Financials Apr 20 2016
CRYO CELL INTERNATIONAL INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial... Apr 19 2016
CRYO CELL INTERNATIONAL INC Files SEC form 8-K, Results of Operations and Financial Condition,... Apr 14 2016
Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2016 Financial Results Apr 14 2016
CRYO CELL INTERNATIONAL INC Files SEC form 10-Q, Quarterly Report Apr 14 2016
CRYO CELL INTERNATIONAL INC Files SEC form 8-K, Changes in Registrant's Certifying Accountant,... Mar 18 2016
CRYO CELL INTERNATIONAL INC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in... Mar 14 2016
CRYO CELL INTERNATIONAL INC Files SEC form 8-K, Results of Operations and Financial Condition,... Mar 02 2016
Cryo-Cell Reports Financial Results for Fiscal 2015 Mar 02 2016
CRYO CELL INTERNATIONAL INC Files SEC form 10-K, Annual Report Feb 29 2016
Cryo-Cell International, Inc. Earnings Q3, 2015 Oct 22 2015
CRYO CELL INTERNATIONAL INC Files SEC form 10-Q, Quarterly Report Oct 15 2015
CRYO CELL INTERNATIONAL INC Files SEC form 8-K, Results of Operations and Financial Condition,... Jul 17 2015
CRYO CELL INTERNATIONAL INC Files SEC form 8-K, Entry into a Material Definitive Agreement,... Jul 16 2015
CRYO CELL INTERNATIONAL INC Files SEC form 10-Q, Quarterly Report Jul 15 2015
CRYO CELL INTERNATIONAL INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders,... Jul 13 2015
CRYO CELL INTERNATIONAL INC Files SEC form 8-K, Entry into a Material Definitive Agreement,... Jun 19 2015
CRYO CELL INTERNATIONAL INC Files SEC form 8-K, Results of Operations and Financial Condition,... Apr 15 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK